1.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Under 22 at diagnosis Sponsor: NCI, Other Protocol IDs: CDR0000467191, COG-ARAR0332, ARAR0332, NCT00304070
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BBI608-201, NCT01325441
|
|
3.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 130046, 13-C-0046, NCT01766635
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 6 months and over Sponsor: Other Protocol IDs: CDR0000066485, BC-AD-2, NCT00003453
|
|
5.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 1 and over Sponsor: Other Protocol IDs: 09-090, NCT01099644
|